CVS Health (CVS) Tops Q3 EPS by 23c, Beats on Revenue; Offers FY25 EPS Guidance
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $104.72 --0%
Revenue Growth %: +1.3%
Financial Fact:
Income before income tax provision: 2.46B
Today's EPS Names:
CRMT, PKE, More
Revenue Growth %: +1.3%
Financial Fact:
Income before income tax provision: 2.46B
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q3 EPS of $1.60, $0.23 better than the analyst estimate of $1.37. Revenue for the quarter came in at $102.9 billion versus the consensus estimate of $98.88 billion.
GUIDANCE:
CVS Health sees FY2025 EPS of $6.55-$6.65, versus the consensus of $6.38.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts ERock Inc (EROC) at Neutral
- Leerink Starts Avalo Therapeutics Inc. (AVTX) at Outperform
- H.C. Wainwright Starts Glaukos Corporation (GKOS) at Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
